Results 121 to 130 of about 27,541,156 (167)

The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors. [PDF]

open access: yesMol Cancer Ther, 2017
Farren MR   +12 more
europepmc   +1 more source

Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. [PDF]

open access: yesOncotarget, 2017
Sekihara K   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Targeting Exportin 1 as treatment for cutaneous squamous cell carcinoma.

Journal of Clinical Oncology, 2023
e21564 Background: Cutaneous squamous cell carcinomas (cSCC) are among the most frequent solid cancers in humans and in the U.S., cSCC cases are increasing. Molecular mechanisms transitioning premalignant lesions to cancer are not well characterized.
Ricky Rana, L. Hansen
semanticscholar   +2 more sources

Exploring the exportin-1 inhibitors for COVID-19 and anticancer treatment

Journal of Biomolecular Structure and Dynamics
Nuclear export protein 1, also known as XPO1, plays a crucial role in cellular homeostasis and assists in the nucleocytoplasmic transfer of ribonucleic acids (RNAs) and proteins.
Tanuj Sharma   +9 more
semanticscholar   +3 more sources

SINE compounds activate exportin 1 degradation through an allosteric mechanism

Nature Chemical Biology
Overexpression of exportin 1 (XPO1/CRM1) in cancer cells mislocalizes numerous cancer-related nuclear export cargoes. Covalent selective inhibitors of nuclear export (SINEs), including the cancer drug selinexor, restore proper nuclear localization by blocking XPO1-cargo interaction.
Casey E. Wing   +16 more
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy